BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai. The facility expands the company’s peptide synthesis ...
Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions. The company—which already boasts production operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results